Management of puberty in constitutional delay of growth and puberty

F. De Luca, J. Argente, L. Cavallo, E. Crowne, H. A. Delemarre-Van de Waal, C. De Sanctis, S. Di Maio, E. Norjavaara, W. Oostdijk, F. Severi, G. Tonini, G. Trifirò, P. G. Voorhoeve, F. Wu

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Constitutional delay of growth and puberty (CDGP) is the most common presenting form of short stature, but no single test can infallibly discriminate CDGP and isolated hypogonadotrophic hypogonadism. Management of puberty in CDGP aims to optimise not only growth - maintaining body proportions and improving peak bone mass without impairing growth potential - but also well-being; for example, the distress boys often suffer because of their lack of growth and pubertal progression can affect their school performance and social relationships. Typical sex steroid treatments to induce puberty in boys with CDGP include testosterone (T) enanthate, T undecanoate, mixed T esters, T transdermal patches, and oxandrolone p.o. Compared with other regimens, short-course low-dose depot T i.m. is an effective, practical, safe, well tolerated, and inexpensive regimen. Some unresolved problems in management include optimal timing and dose of sex steroid treatment, the role of GH in CDGP, and the management of CDGP in girls.

Original languageEnglish
Pages (from-to)953-957
Number of pages5
JournalJournal of Pediatric Endocrinology and Metabolism
Volume14
Issue numberSUPPL. 2
Publication statusPublished - 2001

Fingerprint

Puberty
Growth
Oxandrolone
Steroids
Transdermal Patch
Hypogonadism
Esters
Bone and Bones
Therapeutics

Keywords

  • Consensus guidelines
  • Constitutional delay of growth and puberty
  • Gonadotrophin
  • Growth
  • Puberty
  • Sex steroid treatment
  • Testosterone

ASJC Scopus subject areas

  • Endocrinology
  • Pediatrics, Perinatology, and Child Health

Cite this

De Luca, F., Argente, J., Cavallo, L., Crowne, E., Delemarre-Van de Waal, H. A., De Sanctis, C., ... Wu, F. (2001). Management of puberty in constitutional delay of growth and puberty. Journal of Pediatric Endocrinology and Metabolism, 14(SUPPL. 2), 953-957.

Management of puberty in constitutional delay of growth and puberty. / De Luca, F.; Argente, J.; Cavallo, L.; Crowne, E.; Delemarre-Van de Waal, H. A.; De Sanctis, C.; Di Maio, S.; Norjavaara, E.; Oostdijk, W.; Severi, F.; Tonini, G.; Trifirò, G.; Voorhoeve, P. G.; Wu, F.

In: Journal of Pediatric Endocrinology and Metabolism, Vol. 14, No. SUPPL. 2, 2001, p. 953-957.

Research output: Contribution to journalArticle

De Luca, F, Argente, J, Cavallo, L, Crowne, E, Delemarre-Van de Waal, HA, De Sanctis, C, Di Maio, S, Norjavaara, E, Oostdijk, W, Severi, F, Tonini, G, Trifirò, G, Voorhoeve, PG & Wu, F 2001, 'Management of puberty in constitutional delay of growth and puberty', Journal of Pediatric Endocrinology and Metabolism, vol. 14, no. SUPPL. 2, pp. 953-957.
De Luca F, Argente J, Cavallo L, Crowne E, Delemarre-Van de Waal HA, De Sanctis C et al. Management of puberty in constitutional delay of growth and puberty. Journal of Pediatric Endocrinology and Metabolism. 2001;14(SUPPL. 2):953-957.
De Luca, F. ; Argente, J. ; Cavallo, L. ; Crowne, E. ; Delemarre-Van de Waal, H. A. ; De Sanctis, C. ; Di Maio, S. ; Norjavaara, E. ; Oostdijk, W. ; Severi, F. ; Tonini, G. ; Trifirò, G. ; Voorhoeve, P. G. ; Wu, F. / Management of puberty in constitutional delay of growth and puberty. In: Journal of Pediatric Endocrinology and Metabolism. 2001 ; Vol. 14, No. SUPPL. 2. pp. 953-957.
@article{51be1342ec204c6aa59f3d14efeb8bb2,
title = "Management of puberty in constitutional delay of growth and puberty",
abstract = "Constitutional delay of growth and puberty (CDGP) is the most common presenting form of short stature, but no single test can infallibly discriminate CDGP and isolated hypogonadotrophic hypogonadism. Management of puberty in CDGP aims to optimise not only growth - maintaining body proportions and improving peak bone mass without impairing growth potential - but also well-being; for example, the distress boys often suffer because of their lack of growth and pubertal progression can affect their school performance and social relationships. Typical sex steroid treatments to induce puberty in boys with CDGP include testosterone (T) enanthate, T undecanoate, mixed T esters, T transdermal patches, and oxandrolone p.o. Compared with other regimens, short-course low-dose depot T i.m. is an effective, practical, safe, well tolerated, and inexpensive regimen. Some unresolved problems in management include optimal timing and dose of sex steroid treatment, the role of GH in CDGP, and the management of CDGP in girls.",
keywords = "Consensus guidelines, Constitutional delay of growth and puberty, Gonadotrophin, Growth, Puberty, Sex steroid treatment, Testosterone",
author = "{De Luca}, F. and J. Argente and L. Cavallo and E. Crowne and {Delemarre-Van de Waal}, {H. A.} and {De Sanctis}, C. and {Di Maio}, S. and E. Norjavaara and W. Oostdijk and F. Severi and G. Tonini and G. Trifir{\`o} and Voorhoeve, {P. G.} and F. Wu",
year = "2001",
language = "English",
volume = "14",
pages = "953--957",
journal = "Journal of Pediatric Endocrinology and Metabolism",
issn = "0334-018X",
publisher = "Walter de Gruyter GmbH & Co. KG",
number = "SUPPL. 2",

}

TY - JOUR

T1 - Management of puberty in constitutional delay of growth and puberty

AU - De Luca, F.

AU - Argente, J.

AU - Cavallo, L.

AU - Crowne, E.

AU - Delemarre-Van de Waal, H. A.

AU - De Sanctis, C.

AU - Di Maio, S.

AU - Norjavaara, E.

AU - Oostdijk, W.

AU - Severi, F.

AU - Tonini, G.

AU - Trifirò, G.

AU - Voorhoeve, P. G.

AU - Wu, F.

PY - 2001

Y1 - 2001

N2 - Constitutional delay of growth and puberty (CDGP) is the most common presenting form of short stature, but no single test can infallibly discriminate CDGP and isolated hypogonadotrophic hypogonadism. Management of puberty in CDGP aims to optimise not only growth - maintaining body proportions and improving peak bone mass without impairing growth potential - but also well-being; for example, the distress boys often suffer because of their lack of growth and pubertal progression can affect their school performance and social relationships. Typical sex steroid treatments to induce puberty in boys with CDGP include testosterone (T) enanthate, T undecanoate, mixed T esters, T transdermal patches, and oxandrolone p.o. Compared with other regimens, short-course low-dose depot T i.m. is an effective, practical, safe, well tolerated, and inexpensive regimen. Some unresolved problems in management include optimal timing and dose of sex steroid treatment, the role of GH in CDGP, and the management of CDGP in girls.

AB - Constitutional delay of growth and puberty (CDGP) is the most common presenting form of short stature, but no single test can infallibly discriminate CDGP and isolated hypogonadotrophic hypogonadism. Management of puberty in CDGP aims to optimise not only growth - maintaining body proportions and improving peak bone mass without impairing growth potential - but also well-being; for example, the distress boys often suffer because of their lack of growth and pubertal progression can affect their school performance and social relationships. Typical sex steroid treatments to induce puberty in boys with CDGP include testosterone (T) enanthate, T undecanoate, mixed T esters, T transdermal patches, and oxandrolone p.o. Compared with other regimens, short-course low-dose depot T i.m. is an effective, practical, safe, well tolerated, and inexpensive regimen. Some unresolved problems in management include optimal timing and dose of sex steroid treatment, the role of GH in CDGP, and the management of CDGP in girls.

KW - Consensus guidelines

KW - Constitutional delay of growth and puberty

KW - Gonadotrophin

KW - Growth

KW - Puberty

KW - Sex steroid treatment

KW - Testosterone

UR - http://www.scopus.com/inward/record.url?scp=0034890413&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034890413&partnerID=8YFLogxK

M3 - Article

VL - 14

SP - 953

EP - 957

JO - Journal of Pediatric Endocrinology and Metabolism

JF - Journal of Pediatric Endocrinology and Metabolism

SN - 0334-018X

IS - SUPPL. 2

ER -